Silvia Montoto

13.8k citations

165 papers · 5.2k indexed · h-index 41

Pathology and Forensic Medicine top 0.2%
Oncology top 0.5%
Hematology top 0.5%
Genetics top 0.5%
Neurology top 1%

Co-authors: Francesc Bosch Jude Fitzgibbon Joan Bladé Mohamad Mohty Nicolaus Kröger Rafael F. Duarte Jan Styczyński Mark Bower
Topics: Lymphoma Diagnosis and Treatment (127 papers)Viral-associated cancers and disorders (66 papers)Chronic Lymphocytic Leukemia Research (42 papers)
Cited by: Pathology and Forensic Medicine Hematology Genetics
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations: United Kingdom Spain France

In The Last Decade

Silvia Montoto

157 papers receiving 5.1k citations

Peers

Countries citing papers authored by Silvia Montoto

Since Specialization

Citations

This map shows the geographic impact of Silvia Montoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Montoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Montoto more than expected).

Fields of papers citing papers by Silvia Montoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Montoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Montoto. The network helps show where Silvia Montoto may publish in the future.

Co-authorship network of co-authors of Silvia Montoto

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Montoto. A scholar is included among the top collaborators of Silvia Montoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Montoto. Silvia Montoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 2021 ·Blood ·Ranjana H. Advani,Tetiana Skrypets,Monica Civallero,Michael A. Spinner,Martina Manni,Won-Seog Kim,Andrei R. Shustov,Steven M. Horwitz,Felicitas Hitz,María Elena Cabrera,Iván Dlouhy,José Vassallo,Stefano Pileri,Giorgio Inghirami,Silvia Montoto,Umberto Vitolo,John Radford,Julie M. Vose,Massimo Federico	60
2	Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial 2021 ·Bone Marrow Transplantation ·Ruth Pettengell,(unknown),Ariane Boumendil,Roderick J. Johnson,Bernd Metzner,Alejandro Martı́n,Joanna Romejko‐Jarosińska,Isabelle Bence‐Bruckler,(unknown),Carsten Utoft Niemann,Stephen Robinson,Eva Kimby,Norbert Schmitz,Peter Dreger,A. H. Goldstone,Silvia Montoto	7
3	How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT 2020 ·Blood Advances ·Olaf Penack,Christophe Peczynski,Mohamad Mohty,Ibrahim Yakoub‐Agha,Jan Styczyński,Silvia Montoto,Rafael F. Duarte,Nicolaus Kröger,Hélène Schoemans,Christian Koenecke,Zinaida Perić,Grzegorz Basak	102
4	Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial 2020 ·SHILAP Revista de lepidopterología ·Elizabeth H. Phillips,Catherine Burton,Amy A. Kirkwood,Sharon Barrans,(unknown),Simon Rule,Russell Patmore,Ruth Pettengell,Kirit M. Ardeshna,Silvia Montoto,Shankara Paneesha,Laura Clifton‐Hadley,David C. Linch,Andrew McMillan	6
5	The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy 2020 ·Bone Marrow Transplantation ·(unknown),Per Ljungman,Małgorzata Mikulska,Rafael de la Cámara,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Harry Dolstra,Arjan C. Lankester,Mohamad Mohty,Silvia Montoto,John Murray,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,(unknown),Nicolaus Kröger,Jan Styczyński	122
6	Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy 2020 ·Bone Marrow Transplantation ·Per Ljungman,Małgorzata Mikulska,Rafael de la Cámara,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Harry Dolstra,Arjan C. Lankester,Mohamad Mohty,Silvia Montoto,John Murray,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,(unknown),Nicolaus Kröger,Jan Styczyński,(unknown)	11
7	Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 2019 ·American Journal of Hematology ·Francine M. Foss,Steven M. Horwitz,Monica Civallero,Monica Bellei,Luigi Marcheselli,Won Seog Kim,María Elena Cabrera,Iván Dlouhy,Arnon Nagler,Ranjana H. Advani,Emanuela Anna Pesce,Young Hyeh Ko,Silvia Montoto,Carlos Chiattone,Alison J. Moskowitz,Michele Spina,Marina Cesaretti,Irène Biasoli,Massimo Federico	38
8	Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation 2019 ·Bone Marrow Transplantation ·(unknown),Eva Domingo‐Doménech,Ariane Boumendil,Fina Climent,Gèrard Socié,Frank Kroschinsky,Hervé Finel,(unknown),Dan Nemet,Matthias Stelljes,Joerg Thomas Bittenbring,Stephen Robinson,Silvia Montoto,Anna Sureda,Peter Dreger	6
9	The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies 2019 ·Bone Marrow Transplantation ·(unknown),Jakob Passweg,Helen Baldomero,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Jürgen Kuball,Arjan C. Lankester,Silvia Montoto,Régis Peffault de Latour,John A. Snowden,Jan Styczyński,Ibrahim Yakoub‐Agha,Mutlu Arat,Mohamad Mohty,Nicolaus Kröger	114
10	Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR 2018 ·Cancer ·Anna Sureda,Mei‐Jie Zhang,Peter Dreger,Jeanette Carreras,Timothy S. Fenske,Hervé Finel,Harry C. Schouten,Silvia Montoto,Stephen Robinson,Sonali M. Smith,(unknown),Mehdi Hamadani,Marcelo C. Pasquini	40
11	The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project 2018 ·Haematologica ·Monica Bellei,Francine M. Foss,Andrei R. Shustov,Steven M. Horwitz,Luigi Marcheselli,Won Seog Kim,María Elena Cabrera,Iván Dlouhy,Arnon Nagler,Ranjana H. Advani,Emanuela Anna Pesce,Young Hyeh Ko,(unknown),Silvia Montoto,Carlos Chiattone,Alison J. Moskowitz,Michele Spina,Irène Biasoli,Martina Manni,Massimo Federico	88
12	Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report 2018 ·Bone Marrow Transplantation ·(unknown),Jakob Passweg,Helen Baldomero,Peter Bader,Grzegorz Basak,Chiara Bonini,Rafael F. Duarte,Carlo Dufour,Nicolaus Kröger,Jürgen Kuball,Arjan C. Lankester,Silvia Montoto,Arnon Nagler,John A. Snowden,Jan Styczyński,Mohamad Mohty	101
13	[ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study 2014 ·Journal of Clinical Oncology ·Maurizio Martelli,Luca Ceriani,Emanuele Zucca,Pier Luigi Zinzani,Andrés J.M. Ferreri,Umberto Vitolo,Caterina Stelitano,Ercole Brusamolino,Maria Giuseppina Cabras,Luigi Rigacci,Monica Balzarotti,Flavia Salvi,Silvia Montoto,Armando López‐Guillermo,Erica Finolezzi,Stefano Pileri,Andrew Davies,Franco Cavalli,Luca Giovanella,Peter Johnson	106
14	HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era 2013 ·AIDS ·Rita Coutinho,Alessia Dalla Pria,(unknown),Katharine Bailey,Paul Fields,Kate Cwynarski,Andrew Wilson,Panagiotis Papanastasopoulos,M Tenant‐Flowers,Andrew Webb,Fiona Burns,Robert Marcus,Chloe Orkin,Silvia Montoto,Mark Bower	45
15	Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database 2012 ·Journal of Clinical Oncology ·Philippe Solal‐Céligny,Monica Bellei,Luigi Marcheselli,Emanuela Anna Pesce,Stefano Pileri,Peter McLaughlin,Stefano Luminari,Barbara Pro,Silvia Montoto,Andrés J.M. Ferreri,Éric Deconinck,Nöel Milpied,Leo I. Gordon,Massimo Federico	88
16	The role of FDG-PET and bone marrow examination in lymphoma staging 2012 ·Annals of Oncology ·(unknown),Tara Barwick,Norbert Avril,Silvia Montoto	4
17	Follicular lymphoma: managing an indolent malignancy 2010 ·British Journal of Hospital Medicine ·Simon Hallam,Silvia Montoto	0
18	Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy 2009 ·British Journal of Haematology ·Tamara Intermesoli,Jonathan Shamash,A. Z. S. Rohatiner,Andrew Wilson,Andrew Lister,Silvia Montoto	1
19	Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma 2007 ·Journal of Clinical Oncology ·Silvia Montoto,Andrew Davies,Janet Matthews,Maria Calaminici,A. J. Norton,John Amess,Sarah Vinnicombe,Rachel Waters,A. Z. S. Rohatiner,T. Andrew Lister	279
20	Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab 2001 ·Annals of Hematology ·Ana Ferrer,(unknown),Silvia Montoto,Teresa Estrach,Lluı́s Colomo,E Montserrat	6

About Silvia Montoto

Silvia Montoto is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 165 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (127 papers), Viral-associated cancers and disorders (66 papers) and Chronic Lymphocytic Leukemia Research (42 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Hematology (1.4k citations) and Genetics (1.3k citations). Silvia Montoto has collaborated with scholars based in United Kingdom, Spain and France. Frequent co-authors include Francesc Bosch, Jude Fitzgibbon, Joan Bladé, Mohamad Mohty, Nicolaus Kröger, Rafael F. Duarte, Jan Styczyński, Mark Bower, John A. Snowden and Armando López‐Guillermo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact